Zydus Pharmaceuticals (USA) Inc recalls
17 recall notices naming Zydus Pharmaceuticals (USA) Inc since January 2025, in United States. The most recent was published 21 Oct 2026.
17recalls on record
Latest recalls (17)
- FDAZydus Pharmaceuticals (USA) Inc recalls Hydrocortisone Sodium Succinate for InjectionFDAFailed Impurities/Degradation Specifications.
- FDAZydus Pharmaceuticals (USA) Inc recalls Mirabegron Extended-Release TabletsFDACGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.
- FDAZydus Pharmaceuticals (USA) Inc recalls Erythromycin TabletsFDACGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit
- FDAZydus Pharmaceuticals (USA) Inc recalls Icosapent Ethyl CapsulesFDAFailed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient.
- FDAZydus Pharmaceuticals (USA) Inc recalls Icosapent Ethyl capsulesFDASubpotent Drug: Due to oxidation caused by leakage of the contents of the capsules
- FDAZydus Pharmaceuticals (USA) Inc recalls traZODONE Hydrochloride TabletsFDAFailed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface.
- FDAZydus Pharmaceuticals (USA) Inc recalls Bromocriptine Mesylate CapsulesFDAFailed Impurities/Degradation Specifications: Out of Specification (OOS) result reported for 2- Bromoergine impurity of Bromocriptine Mesylate…
- FDAZydus Pharmaceuticals (USA) Inc recalls clomiPRAMINE HydrochlorideFDACGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above…
- FDAZydus Pharmaceuticals (USA) Inc recalls Entecavir TabletsFDAFailed impurity/degradation specifications:Out of Specification result for an individual organic impurity
- FDAZydus Pharmaceuticals (USA) Inc recalls Entecavir TabletsFDAFailed Impurity/Degradation Specifications
- FDAZydus Pharmaceuticals (USA) Inc recalls Succinylcholine Chloride InjectionFDAFailed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation impurity.
- FDAZydus Pharmaceuticals (USA) Inc recalls Chlorpromazine Hydrochloride TabletsFDACGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
- FDAZydus Pharmaceuticals (USA) Inc recalls Icosapent Ethyl Capsules 1 gramFDAFailed Tablet/Capsule specifications; a product complaint was reported for burnt or melted capsules. This was determined to be a result of oxidation…
- FDAZydus Pharmaceuticals (USA) Inc recalls Esomeprazole Magnesium for Delayed-Release Oral SuspensionFDAFailed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation product during…
- FDAZydus Pharmaceuticals (USA) Inc recalls Venlafaxine TabletsFDAPresence of Foreign Substance: Product complaint received for the presence of foreign material embedded resembling a metal shaving in one tablet.
- FDAZydus Pharmaceuticals (USA) Inc recalls chlorproMAZINE Hydrochloride TabletsFDACGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit
- FDAZydus Pharmaceuticals (USA) Inc recalls Nelarabine InjectionFDAFailed Impurities/Degradation Specifications